Fellowship Opportunities

BWH-MGH Multiple Sclerosis & Neuroimmunology Fellowship Program

(Clinical & Clinical Research Tracks)

The application cycle for AY25 (July 1, 2024-June 30, 2025) has closed. We will open applications for AY26 in the summer of 2023.

Inquiries may be sent to Taylor at msfellowship@partners.org.

Program Leadership:

• Dr. Tanuja Chitnis, Director
• Dr. Kristin Galetta, Associate Director
• Dr. Eric Klawiter, Site Director (MGH)

The BWH-MGH MS and Neuroimmunology (MSNI) Fellowship Program (formerly known as the Partners MS Fellowship Program) is one of the most sought-after training programs in its field and has trained 16 clinical fellows since 2011 to meet the growing needs of MS and neuroimmunology patients. The MSNI Program is a hybrid program comprised of clinical and clinical research tracks offered through the Brigham and Women’s Hospital (BWH) and Massachusetts General Hospital (MGH), academically affiliated with Harvard Medical School (HMS). The program has had an excellent track record of doing so, with 100% of recent graduates remaining as MS specialists. More than 80% hold academic positions in MS Centers and are currently training their own fellows. In addition, these Fellows participate in ongoing clinical research studies, both within the clinical setting and in conjunction with our affiliated research center, the Ann Romney Center for Neurologic Diseases (ARCND). Fellows are also academically credentialed through Harvard Medical School (HMS).Training is comprised of directly supervised MS patient care, exposure to multidisciplinary care, and inpatient management. To complement the in-clinic training, we have developed a comprehensive educational curriculum led by our expert faculty consisting of MS clinical case conferences, MRI review, MS seminars and clinical and research seminars focused on neuroimmunology more broadly. The infrastructure of the Program is consistent for both the clinical and clinical research tracks. Fellows completing the MSNI Fellowship Program will develop a strong knowledge base in MS pathophysiology, epidemiology, diagnosis, and management as well as subspecialty topics including women’s health and progressive MS. In addition, the Fellow will develop expertise in the management of NMOSD, MOGAD, and autoimmune encephalitis. Accordingly, they will understand differential diagnostic considerations and how to apply them to a particular clinical situation. The overall goal is to achieve excellence and independence in the comprehensive care of people with MS.

Clinical Fellows:

• Rotate through the Brigham MS Center at the Brigham and Women’s Hospital for 1-2 years in preparation for a career as a MS specialist.
• Training is comprised of direct supervised MS patient care, exposure to multidisciplinary care, and didactic activities.
• The clinical fellowship involves 5 supervised clinics each week and exposure to ongoing research activities at the Brigham MS Center.

Clinical Research Fellows:

• This track involves supervised clinics in MS, NMO, and Neuroimmunology (across multiple institutions) and a focused research trajectory.
  • CLIMB: Conduct research in biomarker clinical correlates and predictors of MS disease course (www.climbstudy.org). PI: Tanuja Chitnis, MD (BWH)
  • Neuroimmunology: NMO mouse models of toleration, MOG T-cell activation studies, TM-familial genetics, and clinical trials – acute and preventative. PI: Michael Levy, MD (MGH)
  • Immunotherapeutics: Clinical translational fellowship focusing on neurotoxicity from CAR-T and oncologic/rheumatologic immunotherapy and development of immunotherapies for newer indications, such as PML and autoimmune encephalitis. PI: Shamik Bhattacharyya, MD (BWH)

The program is funded by Biogen, Genentech, and the National Multiple Sclerosis Society; individual fellowship funding opportunities may be applied for. This program is internally reviewed by the Mass General Brigham (MGB) Education Committee and administered by MGB Graduate Medical Education (GME). Eligible applicants will have successfully completed a residency training program in the US or Canada. Please reference the institutional policy surrounding USMLE completion for clinical trainees.

Harvard Combined Pediatric Multiple Sclerosis and Neuroimmunology Fellowship

The application cycle for AY25 (July 1, 2024-June 30, 2025) has closed. We will open applications for AY26 in the summer of 2023.

Inquiries may be sent to Taylor at msfellowship@partners.org.

• Program Leadership: Tanuja Chitnis, MD & Mark Gorman, MD
• Fellows rotate through the pediatric MS and neuroimmunology clinics at Massachusetts General Hospital (with Dr. Chitnis) and at Boston Children’s Hospital (with Dr. Gorman), and adult MS clinic at Brigham and Women’s Hospital (with Dr. Chitnis).
• Fellows will learn about pediatric MS, NMO and related demyelinating disorders (DD) and will build a knowledge base regarding MS, NMO and DD clinical care.
• For additional information regarding this fellowship, please visit our pediatric site.

We are currently accepting applications for AY25 (July 2024 – June 2025). Applications are due by December 1, 2022.

• Please submit your CV and personal statement outlining your career objectives and rationale for choosing this program. We will also require two (2) letters of recommendation sent directly by the referee, which are due by the application deadline. Please email your application materials to Taylor at msfellowship@partners.org and do not hesitate with questions related to your application and/or the program.

Postdoctoral Research Fellowship

At this time, we currently do not have available opportunities. Inquiries may be sent to msfellowship@partners.org.